Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Approved PLCO Projects

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Reset
Results: 1467 (Showing 501 to 520)
Name Principal Investigator Institution Study Date Approved Project ID
Serum levels of per- and polyfluorinated substances and risks of non-Hodgkin lymphoma and thyroid cancer Mark Purdue DCEG, NCI PLCO Sep 18, 2020 2020-0003
Cancer survival analysis using semisupervised learning method based on Cox and AFT models with L1/2 regularization Vaishali Gadhiya Laurentian University PLCO Sep 16, 2020 PLCO-666
Characteristics associated with weightlifting, cancer risk and associated mortality Jessica Gorzelitz NCI / DCEG / MEB PLCO Sep 10, 2020 PLCO-665
DNA methylation and breast cancer risk Jirong Long Vanderbilt University Medical Center PLCO Sep 1, 2020 PLCO-663
Consumption of sugar, sugar-sweetened beverages and liver cancer Katherine McGlynn National Cancer Institute PLCO Sep 1, 2020 PLCO-664
Estimate heritability of survival for selected diseases Jianxin Shi National Cancer Institute PLCO Aug 20, 2020 PLCO-661
Risk Factors for Lung Cancer in Never Smokers: Insight from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset Farouk Dako University of Pennsylvania PLCO Aug 18, 2020 PLCO-660
Associations between Dietary Plant Seed Consumption and Overall and Cause-Specific Mortality Risk Jiaqi Huang National Cancer Institute PLCO Aug 5, 2020 PLCO-653
Germline genetics of prostate cancer, PSA, and BPH using the expanded PLCO GWAS Sonja Berndt National Cancer Institute PLCO Aug 5, 2020 PLCO-659
Using Machine Learning for the Early Diagnosis of Pancreatic Cancer Carol Hersh Great Neck South High School PLCO Jul 21, 2020 PLCO-651
BRCA and HNPCC Carriers in PLCO Paul Pinsky NCI PLCO Jul 17, 2020 PLCO-644
Impact of Prostatitis and Benign Prostate Hyperplasia (BPH) on risk factors for Prostate Cancer Andrew Marks Claremont Graduate University PLCO Jul 17, 2020 PLCO-641
Prediction of an individual's smoking habits using saliva microbial signatures Manfred Kayser Erasmus MC Medical Center University Rotterdam PLCO Jul 17, 2020 PLCO-647
Blood groups and inflammatory marker levels Charles Rabkin DCEG PLCO Jul 17, 2020 PLCO-646
Genderd differences in stage and radiotherapy Cristina Sarasqueta Instituto Biodonostia PLCO Jun 26, 2020 PLCO-640
Evaluating six-step parsimonious quadratic logistic regression for risk prediction Stuart Baker National Cancer Institute PLCO Jun 18, 2020 PLCO-637
Verifying Explanatory Methods Thomas Lukasiewicz University of Oxford PLCO Jun 18, 2020 PLCO-638
Diet and lifestyle factors and lung cancer risk and mortality: Classification and regression tree analysis Qian Wang University Hospitals Seidman Cancer Center PLCO Jun 9, 2020 PLCO-633
Coffee consumption and risk of renal cell carcinoma in the PLCO cohort Jongeun Rhee NCI PLCO Jun 9, 2020 PLCO-632
Genome wide association study (GWAS) of cholangiocarcinoma (CCA) Katherine McGlynn National Cancer Institute PLCO Jun 2, 2020 PLCO-631